TITLE:
Report on Anti-Tuberculosis Treatment in Patients Monitored Health Center in Dakar, Senegal
AUTHORS:
Mouhamadou Thiam, Aminata Ba, Abdou Faye, Mouhamadou Moustapha Boye, Serigne Mbaye Lo Ndiaye, Rokhaya Sy, Madièye Sene
KEYWORDS:
Anti-Tuberculosis Treatment, Report on, Nabil Choucair Health Center
JOURNAL NAME:
Open Journal of Medical Microbiology,
Vol.15 No.4,
December
11,
2025
ABSTRACT: Introduction: Tuberculosis is a contagious infectious disease caused by a mycobacterium of the tuberculosis complex. It remains a serious disease worldwide despite the efforts made to eradicate it. This study aims to evaluate the outcome of anti-tuberculosis treatment in patients treated at the Nabil Choucair Health Center. Methodology: This was a retrospective, descriptive and analytical study which took place between January 2023 and December 2024, covering a period of 2 years. The work covered all patients diagnosed with tuberculosis and who received their anti-tuberculosis treatment at the Nabil Choucair Health Center. Results: We collected 707 patients with a median age of 32 years (minimum: 9 months and maximum: 88 years). The sex ratio was 2.3. The age groups 15 - 25 years and 25 - 35 years were represented in our study with respectively 28.1% and 27.9% of the study population. Pulmonary site of tuberculosis was the most encountered in our cohort (85.3%), followed by pleural (4.7%), lymph node (3.7%) and vertebral (3.4%). Regarding the therapeutic regimen, 96.5% of patients received a 6-month treatment according to the 2RHZE/4RH regimen, while 3.5% received a 12-month treatment according to the 2RHZE/10RH regimen. The treatment results of the patients in our study were marked by a therapeutic success (completed + cured) which was around 84.3%, including 72.3% cured and 12.4% completed. Those lost to follow-up and those deceased represented 9.9% and 3.8% of cases respectively. Statistical analysis revealed a significant association between treatment outcome and the form, site of tuberculosis and HIV status (p Conclusion: The monitoring of patients undergoing anti-tuberculosis treatment is satisfactory at the Nabil Choucair health center. Nevertheless, efforts are needed to reduce the number of deaths and treatment failures.